Liping Wang

(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Dooseop Kim, Liping Wang, Maria Beconi et al. · Journal of Medicinal Chemistry · 2004 · 817 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Multi-functional bismuth-doped bioglasses: combining bioactivity and photothermal response for bone tumor treatment and tissue repair

Liping Wang, Nicholas J. Long, Lihua Li et al. · Light Science & Applications · 2018 · 431 citations · Full text

Natural Sciences, Materials Engineering, Materials Science +13

An atypical R2R3 <scp>MYB</scp> transcription factor increases cold hardiness by <scp>CBF</scp>‐dependent and <scp>CBF</scp>‐independent pathways in apple

Yinpeng Xie, Pengxiang Chen, Yan Yan et al. · New Phytologist · 2017 · 377 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +17

Discovery of 5-[[4-[(2,3-Dimethyl-2<i>H</i>-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor

Philip A. Harris, Amogh Boloor, Mui Cheung et al. · Journal of Medicinal Chemistry · 2008 · 345 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

The Neuroblastoma-Associated F1174L ALK Mutation Causes Resistance to an ALK Kinase Inhibitor in ALK-Translocated Cancers

Takaaki Sasaki, Katsuhiro Okuda, Wei Zheng et al. · Cancer Research · 2010 · 329 citations · Full text

Medicine, Oncology, Pharmacology +17